Ardelyx (ARDX) Inventory Average (2022 - 2026)
Ardelyx posted quarterly Inventory Average of $20.2 million for Q1 2026, down 9.94% year-on-year from $22.5 million in Q1 2025, and down 5.66% on a QoQ basis from $21.5 million in Q4 2025.
Ardelyx (ARDX) has 5 years of Inventory Average data on file, last reported at $20.2 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average fell 9.94% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (down 9.94% YoY), and the FY2025 full-year result was $19.5 million, up 15.73% from the prior year.
- Inventory Average for Q1 2026 stood at $20.2 million, down from $21.5 million in the prior quarter.
- Across five years, Inventory Average topped out at $23.7 million in Q3 2025 and bottomed at $2.3 million in Q4 2022.
- The 5-year median for Inventory Average is $11.5 million (2024), against an average of $12.5 million.
- The widest annual swing landed in 2023, when Inventory Average jumped 362.75%; it then decreased 9.94% in 2026.
- A 5-year view of Inventory Average shows it stood at $2.3 million in 2022, then jumped by 362.75% to $10.5 million in 2023, then soared by 55.21% to $16.3 million in 2024, then soared by 31.81% to $21.5 million in 2025, then fell by 5.66% to $20.2 million in 2026.
- The last three Inventory Average figures came in at $20.2 million (Q1 2026), $21.5 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 20.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.24 Mn |
| Dec 31, 2025 | 21.45 Mn |
| Sep 30, 2025 | 23.72 Mn |
| Jun 30, 2025 | 23.03 Mn |
| Mar 31, 2025 | 22.47 Mn |
| Dec 31, 2024 | 16.28 Mn |
| Sep 30, 2024 | 12.57 Mn |
| Jun 30, 2024 | 11.78 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | 8.07 Mn |
| Jun 30, 2023 | 6.22 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 4.01 Mn |